These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8906292)

  • 1. Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy.
    Nicolodi M; Sicuteri F
    Adv Exp Med Biol; 1996; 398():373-9. PubMed ID: 8906292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAOIs in the contemporary treatment of depression.
    Thase ME; Trivedi MH; Rush AJ
    Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome.
    Tort S; Urrútia G; Nishishinya MB; Walitt B
    Cochrane Database Syst Rev; 2012 Apr; (4):CD009807. PubMed ID: 22513976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic antidepressants and fibromyalgia: what is the mechanism of action?
    Lawson K
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1437-45. PubMed ID: 12387704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression.
    Merikangas KR; Merikangas JR
    Biol Psychiatry; 1995 Nov; 38(9):603-10. PubMed ID: 8573662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase-inhibiting antidepressants. A clinical update.
    Murphy DL; Sunderland T; Cohen RM
    Psychiatr Clin North Am; 1984 Sep; 7(3):549-62. PubMed ID: 6384960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the role of tricyclic medications in the treatment of fibromyalgia syndrome.
    Goldenberg DL
    J Rheumatol Suppl; 1989 Nov; 19():137-9. PubMed ID: 2691673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of cyclobenzaprine for the treatment of fibromyalgia.
    Quimby LG; Gratwick GM; Whitney CD; Block SR
    J Rheumatol Suppl; 1989 Nov; 19():140-3. PubMed ID: 2481741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Hydroxytryptophan: a clinically-effective serotonin precursor.
    Birdsall TC
    Altern Med Rev; 1998 Aug; 3(4):271-80. PubMed ID: 9727088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibromyalgia and headache. Failure of serotonergic analgesia and N-methyl-D-aspartate-mediated neuronal plasticity: their common clues.
    Nicolodi M; Volpe AR; Sicuteri F
    Cephalalgia; 1998 Feb; 18 Suppl 21():41-4. PubMed ID: 9533670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAOIs: still here, still dangerous.
    Ahmed DS; Fecik S
    Am J Nurs; 2000 Feb; 100(2):29-30. PubMed ID: 10683640
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study.
    Sarzi Puttini P; Caruso I
    J Int Med Res; 1992 Apr; 20(2):182-9. PubMed ID: 1521674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine and amitriptyline in the treatment of fibromyalgia.
    Johnson SP
    J Fam Pract; 1997 Feb; 44(2):128-30. PubMed ID: 9040508
    [No Abstract]   [Full Text] [Related]  

  • 15. EULAR revised recommendations for the management of fibromyalgia.
    Macfarlane GJ; Kronisch C; Dean LE; Atzeni F; Häuser W; Fluß E; Choy E; Kosek E; Amris K; Branco J; Dincer F; Leino-Arjas P; Longley K; McCarthy GM; Makri S; Perrot S; Sarzi-Puttini P; Taylor A; Jones GT
    Ann Rheum Dis; 2017 Feb; 76(2):318-328. PubMed ID: 27377815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amitriptyline for the treatment of fibromyalgia: a comprehensive review.
    Rico-Villademoros F; Slim M; Calandre EP
    Expert Rev Neurother; 2015 Oct; 15(10):1123-50. PubMed ID: 26395929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibromyalgia and the serotonin pathway.
    Juhl JH
    Altern Med Rev; 1998 Oct; 3(5):367-75. PubMed ID: 9802912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.
    Shulman KI; Fischer HD; Herrmann N; Huo CY; Anderson GM; Rochon PA
    J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic function in the affective disorders: the effect of antidepressants and lithium on the 5-hydroxytryptophan-induced increase in serum cortisol.
    Meltzer HY
    Ann N Y Acad Sci; 1984; 430():115-37. PubMed ID: 6378031
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
    Russo EB
    Neuro Endocrinol Lett; 2004; 25(1-2):31-9. PubMed ID: 15159679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.